10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615 | -26.1% | 14,900 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $832 | +4.3% | 14,900 | +4.2% | 0.00% | -20.0% |
| Q1 2023 | $798 | +53.2% | 14,300 | 0.0% | 0.01% | +66.7% |
| Q4 2022 | $521 | -99.9% | 14,300 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $407,000 | -37.1% | 14,300 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $647,000 | -35.0% | 14,300 | +9.3% | 0.00% | -33.3% |
| Q1 2022 | $995,000 | -45.2% | 13,082 | +7.4% | 0.01% | -33.3% |
| Q4 2021 | $1,815,000 | +66.5% | 12,182 | +62.8% | 0.01% | +50.0% |
| Q3 2021 | $1,090,000 | -25.6% | 7,484 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $1,466,000 | -36.2% | 7,484 | -41.1% | 0.01% | -38.5% |
| Q1 2021 | $2,299,000 | +18.5% | 12,700 | -7.3% | 0.01% | +8.3% |
| Q4 2020 | $1,940,000 | – | 13,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |